Nebenwirkungen · Myocet liposomal (previously Myocet)
Myocet liposomal 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion. · Abschnitt 4.8 · PDF-Seite 7–8
HOS-091148 · Präparat HOS-084209
7 All grades Grades ≥ 3 Skin and subcutaneous tissue disorders Alopecia Very Common Common Rash Common Not known Palmar-plantar Not known Not known erythrodysaesthesia syndrome Nail disorder Common Uncommon Pruritus Uncommon Uncommon Folliculitis Uncommon Uncommon Dry skin Uncommon Not known Musculoskeletal and connective tissue disorders Back pain Common Uncommon Myalgia Common Uncommon Muscle weakness Uncommon Uncommon Renal and urinary disorders Haemorrhagic cystitis Uncommon Uncommon Oliguria Uncommon Uncommon General disorders and administration site conditions Asthenia/Fatigue Very Common Common Fever Very common Common Pain Very Common Common Rigors Very Common Uncommon Dizziness Common Uncommon Headache Common Uncommon Weight loss Common Uncommon Injection site reaction Uncommon Uncommon Malaise Uncommon Not known
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-06-06T15:00:00Z · SHA-256 8f879c8b42a8f86dde725e12460699033047270c72b2613905f3d2414bc6cff4 · Passage ab389b9196292f468a29e7263d87b8b8d660586acbaf577a360bd741471a9503 · Zeichen 4010–5889 im Abschnitt